Doris Capsule (Triflusal)

Adult dose

Adults: Administer 600 mg ∼ 900 mg of triflusal per day orally in divided doses during or after meals. This drug should preferably be taken with meals.

This medication should not be used in women who are pregnant or may become pregnant. It is safe to withhold treatment from patients with peptic ulcers or a history of peptic ulcers. Patients allergic to this medication, its components, or salicylate derivatives should not take it. This medication should also not be administered to patients who are currently bleeding. Patients with renal or liver function impairment should exercise special caution when using this medication, and it should also be administered carefully to patients at risk of bleeding. While taking this medication, gastrointestinal discomfort such as abdominal pain, dyspepsia, and nausea may occur, which can be alleviated by taking with meals or using antacids. Rarely, side effects such as gastrointestinal bleeding, skin rashes, headache, dizziness, hearing loss, anemia, and bleeding may occur, so any unusual symptoms should prompt immediate consultation with a healthcare provider. For patients with renal or liver disorders, experience with this drug is limited, thus they should follow their physician's instructions closely, and caution is also required in cases of bleeding risk. This medication may increase the risk of bleeding; thus, patients at risk of bleeding or those about to undergo surgery should discontinue use at least 7 days prior to the procedure. When used in combination with anticoagulants or oral hypoglycemics, drug interactions may enhance effects, necessitating dosage adjustments and close monitoring. Women who are pregnant or may become pregnant should not take this medication, and its use is not recommended in children under 18 years of age due to the lack of established safety and efficacy. In the event of overdose, central nervous system disturbances, cardiac and respiratory issues, and gastrointestinal bleeding may occur, and immediate medical attention should be sought for appropriate treatment. This medication should be kept out of reach of children, and transferring to other containers may lead to accidents or quality deterioration.

Abdominal pain, dysphagia, heartburn, indigestion, nausea, peptic bleeding, melena, conjunctival hemorrhage, petechiae, hearing impairment, migraine, itchiness, rash, headache, confusion, dizziness, lightheadedness, seizures, tinnitus, hearing loss, taste distortion, abdominal pain, constipation, vomiting, bloating, loss of appetite, diarrhea, gastrointestinal bleeding, black stools, rectal bleeding, hypertension, transient ischemic attack, cerebral hemorrhage, dyspnea, upper respiratory infection, anemia, nosebleeds, hematoma, purpura, gum bleeding, hematuria, urinary tract infection, abdominal distension, fever, influenza-like symptoms, photosensitivity reaction, symptoms of central nervous system excitation or inhibition, changes in heart circulatory and respiratory systems, changes in electrolyte balance, diarrhea

This medication should be stored in a tightly closed container to protect it from air and moisture. It is advisable to maintain storage temperatures between 1 and 30 degrees Celsius.

Appearance

A hard capsule containing a bed of crystals or white crystalline powder in a colorless transparent hard shell.

Package unit

30 capsules/bottle, 100 capsules/bottle